Development of Essential Oil Delivery Systems by ‘Click Chemistry’ Methods: Possible Ways to Manage Duchenne Muscular Dystrophy

Abstract

Recently, rare diseases have received attention due to the need for improvement in diagnosed patients’ and their families’ lives. Duchenne muscular dystrophy (DMD) is a rare, severe, progressive, muscle-wasting disease. Today, the therapeutic standard for treating DMD is corticosteroids, which cause serious adverse side effects. Nutraceuticals, e.g., herbal extracts or essential oils (EOs), are possible active substances to develop new drug delivery systems to improve DMD patients’ lives. New drug delivery systems lead to new drug effects, improved safety and accuracy, and new therapies for rare diseases. Herbal extracts and EOs combined with click chemistry can lead to the development of safer treatments for DMD. In this review, we focus on the need for novel drug delivery systems using EOs as the therapy for DMD and the potential use of click chemistry for drug delivery systems. New EO complex drug delivery systems may offer a new approach for improving muscle conditions and mental health issues associated with DMD. However, further research should identify the potential of these systems in the context of DMD. In this review, we discuss possibilities for applying EOs to DMD before implementing expensive research in a theoretical way.

Targeted Antisense Oligonucleotide-Mediated Skipping of Murine Postn Exon 17 Partially Addresses Fibrosis in D2.mdx Mice

“…In addition to the potential of the combinational approach, our exon-skipping strategy could benefit from recent advancements in delivery vectors for DMD therapeutics. Innovations such as nanoparticles [ 49 ] and click-chemistry conjugate synthesis [ 50 ] have shown significant promise in enhancing drug delivery and achieving specific tissue targeting [ 51 ]. While our current study employed vivoPMO dendrimer conjugation, exploring alternative delivery methods may further enhance the efficiency, specificity, and overall effectiveness of the treatment.…”

Unraveling Complex Hysteresis Phenomenon in 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine Monolayer: Insight into Factors Influencing Surface Dynamics

“…An example of a nanocarrier that illustrates this concept is the solid lipid nanoparticle, which consists of a lipid core enveloped by a surfactant monolayer. The controlled manipulation of lipid monolayers is integral to the design of such nanocarriers, ensuring that they release drugs in a manner that meets specific therapeutic requirements [12,13].…”